Skip to main content
BIIB $253.40 +1.17%
BIIB logo
BIIB · Biogen Inc.
Track BIIB — free
Market Cap
$37.46B
Shares
147.82M
Volume · Nov 13 1.03M Avg daily vol (3M) 1.07M
All webcasts

Earnings call · FY2019 Q4

Biogen Inc. (BIIB) Q4 2019 Earnings Call

Concluded Jan 30, 2020
Jan 30, 2020
Period
FY2019 Q4
Runtime
—
Sources
2 artifacts
Revenue $3.67B +4.1% YoY
Diluted EPS $8.08 +70.8% YoY
Gross margin 87.8% +1.7 pp YoY
Net income $1.44B +52.1% YoY
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$2.92B +3.5% YoY
Revenuesfromanticd20therapeuticprograms$600.80M +12.3% YoY
Product And Service Other$145.70M -12.1% YoY
Full-screen source Call document